Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582036 · ClinicalTrials.gov registry record · NA
Glucose Control In Hematopoetic Stem Cell Transplant
A NA study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00582036 is a NA study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 11 participants.
The verdict
NCT00582036, a NA study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucose goal 110 mg/dl) using continuous IV insulin and glucose vs. non-intensive glucose management (goal 200 mg/dl)
Interventions
- DRUG Regular Insulin
- DEVICE Deployment of the MiniMed Paradigm monitoring device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582036
The ClinicalTrials.gov registry entry for NCT00582036 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Regular Insulin is the first listed.
NCT00582036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582036 about?
NCT00582036 is a clinical study titled "Glucose Control In Hematopoetic Stem Cell Transplant". To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucose goal 110 mg/dl) using continuous IV insulin and glucose vs. non-intensive glucose management (goal 200 mg/dl)
What is the current status of trial NCT00582036?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2007-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00582036?
The interventions under investigation include: Regular Insulin (DRUG), Deployment of the MiniMed Paradigm monitoring device (DEVICE).
Who is sponsoring clinical trial NCT00582036?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.